Editorial: immune dysfunction in nephrotic syndrome – recent advances and new roads ahead

HIGHLIGHTS

• who: Barbara Seitz-Polski from the Osaka University, Japan have published the research: Editorial: Immune dysfunction in nephrotic syndrome - recent advances and new roads ahead, in the Journal: (JOURNAL)
• what: The pathogenesis of MCD and FSGS have not yet been resolved, and the major focus was on immunomodulatory therapies targeting CD20, which have been developed over the last few years which and are linked with the production of antibodies.

SUMMARY

Secondary forms also exist as part of more complex settings, such as viral infections (e_g cytomegalovirus, Epstein Barr virus, SARS-CoV2 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.